GlobeNewswire/Press Release German

Actelion Pharmaceuticals Ltd / Press Release German . Verarbeitet und übermittelt durch Nasdaq Corporate Solutions. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. Source: Globenewswire

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Actelion Pharmaceuticals Ltd via Globenewswire

--- Ende der Mitteilung ---

Actelion Pharmaceuticals Ltd

Gewerbestrasse 16 Allschwil Schweiz

ISIN: CH0010532478;

http://www.actelion.com (END) Dow Jones Newswires

   January 26, 2017 03:08 ET (08:08 GMT)- - 03 08 AM EST 01-26-17